Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Paul Michael

Interventional Cardiology Sebring, FL Medical Doctor

NPI 1477879229 CMS profile 747383

4240 Sun N Lake Blvd Ste 202, Sebring, FL 33872

Open in the dashboard

General payments

$236,364

446 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Paul Michael of Sebring, FL is reported in the CMS Open Payments database as having received $236,364 across 446 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $301 8
2024 General $3,250 21
2023 General $43,576 42
2022 General $60,379 77
2021 General $28,236 71
2020 General $37,980 84
2019 General $62,641 143

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Michael
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Paul Michael were reported at $301. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Paul Michael Interventional Cardiology median Middle half National median
2019 $62,641 $1,097 $329–$3,048 $163
2020 $37,980 $473 $161–$1,480 $114
2021 $28,236 $677 $233–$1,827 $132
2022 $60,379 $978 $333–$2,724 $149
2023 $43,576 $1,136 $382–$2,986 $160
2024 $3,250 $1,181 $395–$3,326 $164
2025 $301 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $85,854 112 payments
  2. Medtronic Vascular, Inc. $43,374 82 payments
  3. Surmodics, Inc. $25,480 33 payments
  4. Abbott Laboratories $24,398 75 payments
  5. Asahi Intecc USA, Inc. $19,527 31 payments
  6. Medtronic, Inc. $16,304 28 payments
  7. AngioDynamics, Inc. $15,472 5 payments
  8. Philips Electronics North America Corporation $3,416 33 payments
  9. Terumo Medical Corporation $667 5 payments
  10. Novo Nordisk Inc $318 3 payments
  11. Other $1,553 39 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $115,825 52 payments
  2. Consulting Fee $45,050 17 payments
  3. Food and Beverage $19,478 330 payments
  4. Honoraria $17,500 3 payments
  5. Travel and Lodging $14,506 37 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $13,800 5 payments
  7. Long term medical supply or device loan $10,167 1 payment
  8. Education $38 1 payment
Products named General payments · program years 2019–2025
  1. Sublime 014 Rx PTA Balloon Dilatation Catheter $26,429 19 payments
  2. JETSTREAM SC $18,200 11 payments
  3. HawkOne $17,010 38 payments
  4. TurboHawk $16,818 9 payments
  5. Omnilink Elite vascular stent system $15,264 6 payments
  6. Sublime Radial Access 018 RX PTA Dilatation Catheter $13,937 12 payments
  7. ASAHI Peripheral Guide Wire $13,163 13 payments
  8. Sublime Microcatheter, 014, 65cm, Angle $12,492 7 payments
  9. Sublime Microcatheter, 014, 65cm, Straight $12,492 7 payments
  10. AngioJet $12,000 4 payments
  11. Other $179,130 443 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

117

Median for Interventional Cardiology: 2,236

Drug cost

$9,233

Median for Interventional Cardiology: $380,412

Branded share of claims

88%

Median for Interventional Cardiology: 27.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xarelto Rivaroxaban Brand 11 $8,171
Clopidogrel Clopidogrel Bisulfate Brand 92 $965
Amlodipine Besylate Generic 14 $97

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 4,694 Part D prescribers listed as Interventional Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 53 billing codes

Paid by Medicare

$99,834

Medicare's payments for the services billed

Medicare patients

216

Average age 77

Services billed

714

85 women, 131 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Arthritis 58%
Heart failure 57%
Diabetes 55%
Chronic kidney disease 53%
COPD 43%
Atrial fibrillation 41%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

446 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record